Alcolase
Summary active Updated May 18, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
Founders
About
Alcolase is a Copenhagen-based biotech developing an enzyme-based supplement to mitigate symptoms of alcohol intolerance (flushing, increased heart rate, dizziness, nausea, headaches) caused by aldehyde dehydrogenase (ALDH2) deficiency, common among East Asian populations 123. The €1.5M seed announced May 18, 2026 was backed by Ada Ventures, Delphinus Venture Capital, Antler, and Manigoff Invest, alongside a group of business angels; proceeds will fund in vivo studies, technology development, intellectual property work, and early commercial partnerships starting in Singapore 123. The company has also established a UK therapeutic subsidiary with Ada Ventures’ support 2.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2026-05-18 | Seed | €1.5M | Ada Ventures | Delphinus Venture Capital, Antler, Manigoff Invest, plus business angels 124 |
What Investors Say
No independently sourced investor quotes found at this time.
What Founders Say
“When you speak to people with alcohol intolerance, you realise this is not about wanting to drink more. It is about not being shut out of dinners, work events and family gatherings because of a genetic difference.” — Mikkel Precht, CEO and co-founder of Alcolase 4
“We want to give people a real choice they are currently denied.” — Mikkel Precht, CEO and co-founder of Alcolase 1
Sources
-
DealStreetAsia, “Danish biotech Alcolase raises $1.7m to tackle alcohol intolerance, eyes SG entry,” May 2026. Accessed May 2026. https://www.dealstreetasia.com/stories/danish-biotech-alcolase-singapore-entry-482418↩↩↩↩
-
Tech.eu, “Alcolase Tag,” May 2026. Accessed May 2026. https://tech.eu/tag/alcolase/↩↩↩↩
-
Nordic 9, “Alcolase raised DKK 1.5 million from angel investor Jesper Lomborg Manigoff,” accessed May 2026. https://nordic9.com/news/alcolase-raised-dkk-15-million-from-angel-investor-jesper-lomborg-manigoff/↩↩
-
Tech Funding News, “Alcolase raises €1.5M to tackle ALDH2 deficiency and alcohol intolerance in East Asia,” May 18, 2026. Accessed May 2026. https://techfundingnews.com/alcolase-1-5m-aldh2-deficiency-alcohol-intolerance-east-asia/↩↩